IE 11 is a very old Browser and it`s not supported on this site
en de
Half-year report 2026
en de
About usBoard of Directors

Board of Directors

EXECUTIVE CHAIRMAN

Veit de Maddalena

Veit de Maddalena is lic. rer. pol. (Economics) from the University of Berne and holds an MSc/Master in Finance from the London Business School. He has many years of leadership experience in the financial industry and is now exclusively active as an independent director on the boards of several family-owned companies. He was elected to the Board of Directors of Bellevue Group in 2018 and has served as its chairman since 2019. Since June 2025, he has held the position of Executive Chairman of the Board of Directors of Bellevue Group. Earlier in his career Veit de Maddalena was a Global Partner and Executive Board member with Rothschild & Co Group, where he was responsible for its global private banking business. He concurrently acted as CEO of Rothschild & Co Bank AG, Switzerland. He began his professional career at Credit Suisse.

MEMBER OF THE BOARD

Barbara Angehrn Pavik

Barbara Angehrn Pavik holds a Bachelor’s and a Master’s degree in Business Administration from the University of St. Gallen. She has more than 20 years of leadership experience in the international biopharmaceutical industry in Europe and the United States. She is currently Chief Executive Officer of Numab Therapeutics AG. Previously, she served as Chief Executive Officer of Asceneuron, a clinical-stage biotechnology company focused on neurodegenerative diseases, where she was responsible for the strategic expansion and advancement of the pipeline. Prior to that, she was Chief Business Officer and a member of the Executive Committee of the Vifor Pharma Group, with responsibility for global commercial and corporate functions. She has also held senior positions at Amgen, Onyx Pharmaceuticals and Exelixis, and was co-founder of Stepstone Pharma, focusing on in-licensing activities outside the United States. Barbara Angehrn Pavik has been a member of the Board of Directors of Bellevue Group since 2023.

LEAD INDEPENDENT  DIRECTOR

Prof. Dr. Urs Schenker

Urs Schenker holds a doctorate in law from the University of Zurich (Dr. iur.) and Harvard (LLM). He is a titular professor at the University of St. Gallen and an attorney at Walder Wyss in Zurich, where he specializes in corporate, finance and capital markets law. Prior to that he worked for approx. 20 years as a lawyer (14 years as a partner) for Baker & McKenzie in Zurich. Urs Schenker has been a member of the Board of Directors since 2019 and has served as Lead Independent Director of Bellevue Group since June 2025.

MEMBER OF THE BOARD

Katrin Wehr-Seiter

Katrin Wehr-Seiter holds a degree in engineering from the Technical University of Chemnitz/DE as well as an MBA from INSEAD Business School, Fontainebleau/FR. Katrin Wehr-Seiter is Partner and CEO of BIP Capital Partners, Luxembourg. Previously, she was a Principal at the international private equity firm Permira and worked as an independent advisor for medium-sized companies and as a Senior Advisor for the financial investor Bridgepoint. She started her professional career at Siemens AG. Since 2019, she has been a member of the Board of Directors of Bellevue Group.